So many glove sour grqpes missed boat and want to buy cheap haha

“There has to be a sterile environment for the vaccine to be bottled. We already have it, and it is furthermore a good manufacturing practice-approved plant. We can bottle the Covid-19 vaccine immediately once it is ready. Our capacity is around 10 million doses per month on 10 doses vial.

Only 2M additional investment needed to accommodate the need as they have the existing plant la sorchai.

if only 2mil budget I also want to invest and compete in this tender. So many glove sour grape.

The Board of Directors of HWGB is pleased to announce that Astramern Nutra V Capsule (previously known as “Astramune-V”) has on 24 August 2020 been informed by the NPRA that the product registration approval has been obtained from 21 August 2020 to 21 August 2025.


https://www.klsescreener.com/v2/announcements/view/3215769

Register supplement also announce. Really gg

Brent green, dow green, qr super green. apa lagi tunguuuuu. Finally warrant will fly tomorrow!

Super impressive results. Unbelievable!!! Beyond happy with this company.

Faster correction so that can in back for dividend.

supersinginvestor James u idiot it means vaccine no use...need time to develop

Need time to develop due to reinfection? Obviously you dont understand how pharmacology of vaccine singinvestor. Better stay in your glove counter and dont come here make people blur like you.

supersinginvestor Hong Kong scientists report the first confirmed case of an apparently healthy patient being re-infected with Covid-19, four months after the first infection

This means more jab is needed. Huat ahh

Great technical sharing kakashi. Keep it coming!

It had deferred two crude oil offtakes initially planned for the current quarter to the next quarter ending Sept 30, 2020 (1QFY21) in an attempt to realise higher crude oil prices.

Brighter days ahead!

By the time you slowly setting the sterile GMP facility all Malaysians kaotim vaccinated. Hahaha

Mampus esok ini counter. Burn kaw kaw by bursa!!

Ouchh! Painful result. My fund may need to rest here at least till 2022 here.

Nicholas is someone that want to create negativity and make newbies anxious. Just ignore this fella.

Thick green today. Tmr sure will gap up 5.5

Ongme88 Finally it almost touch my buying price rm5.10!
Been waiting for more than a month
Sifu here .... should I sell or hold?

You should’ve average down when it was below 4. Anyway the next resistant at 5.55.

Roadblock at 5. Pass this then flyyy

Get on board before its too late.

Company listed since 2005 and the all time highest share price was only at 0.35 in 2017. Whoever at 59th floor do pray hard and run for your life as soon as possible.

So many glove sohai wanna live with covid forever. Really pathetic.

https://www.biofarma.co.id/bio-farma-pastikan-supply-50-juta-dosis-bulk-vaksin-covid-19-dari-sinovac-2/

Dalam agreement tersebut, Bio Farma tidak hanya sekedar mengolah dan mendistribusikan saja, tetapi juga ada unsur transfer teknologi, “Dalam kunjungan ini kita ingin memastikan transformasi dari industri kesehatan kita, di mana Bio Farma kerja sama dengan Sinovac adalah sebuah kerja sama yang win-win, bahwa menyepakati dengan Sinovac dalam hal transfer knowledge, transfer teknologi, ini yang perlu digaris bawahi.” Ujar Erick.

https://www.biofarma.co.id/bio-farma-pastikan-supply-50-juta-dosis-bulk-vaksin-covid-19-dari-sinovac-2/

Dalam agreement tersebut, Bio Farma tidak hanya sekedar mengolah dan mendistribusikan saja, tetapi juga ada unsur transfer teknologi, “Dalam kunjungan ini kita ingin memastikan transformasi dari industri kesehatan kita, di mana Bio Farma kerja sama dengan Sinovac adalah sebuah kerja sama yang win-win, bahwa menyepakati dengan Sinovac dalam hal transfer knowledge, transfer teknologi, ini yang perlu digaris bawahi.” Ujar Erick.

JAKARTA (Bloomberg): Indonesia signed an agreement with China's Sinovac Biotech for 50 million doses of Covid-19 vaccine concentrate that will allow state-owned PT Bio Farma to produce doses locally.

Sinovac will ship the concentrate in five equal stages between November and March, vaccine maker Bio Farma said in a statement on Saturday (Aug 22).

Beijing-based Sinovac also granted priority access for bulk supply to Indonesia until the end of 2021.

https://www.thestar.com.my/aseanplus/aseanplus-news/2020/08/22/indonesia-signs-agreement-with-sinovac-for-covid-19-vaccine

Indonesia has secured the deal with Sinovac and look how much the share price of PT Kimia Farma Tbk (KAEF) and PT Indofarma Tbk (INAF) have risen since early July.

oilwaterman hello bro you better hold tight you glove counters. No need everyday spam same brainless post.

JAKARTA (Bloomberg): Indonesia signed an agreement with China's Sinovac Biotech for 50 million doses of Covid-19 vaccine concentrate that will allow state-owned PT Bio Farma to produce doses locally.

Sinovac will ship the concentrate in five equal stages between November and March, vaccine maker Bio Farma said in a statement on Saturday (Aug 22).

Beijing-based Sinovac also granted priority access for bulk supply to Indonesia until the end of 2021.

https://www.thestar.com.my/aseanplus/aseanplus-news/2020/08/22/indonesia-signs-agreement-with-sinovac-for-covid-19-vaccine

Indonesia has secured the deal with Sinovac and look how much the share price of PT Kimia Farma Tbk (KAEF) and PT Indofarma Tbk (INAF) have risen since early July.

JAKARTA (Bloomberg): Indonesia signed an agreement with China's Sinovac Biotech for 50 million doses of Covid-19 vaccine concentrate that will allow state-owned PT Bio Farma to produce doses locally.

Sinovac will ship the concentrate in five equal stages between November and March, vaccine maker Bio Farma said in a statement on Saturday (Aug 22).

Beijing-based Sinovac also granted priority access for bulk supply to Indonesia until the end of 2021.

https://www.thestar.com.my/aseanplus/aseanplus-news/2020/08/22/indonesia-signs-agreement-with-sinovac-for-covid-19-vaccine

Indonesia has secured the deal with Sinovac and look how much the share price of PT Kimia Farma Tbk (KAEF) and PT Indofarma Tbk (INAF) has risen since early July.

If Drop below 60 sapuuuuu

https://koonyewyin.com/2020/08/22/vaccine-will-not-reduce-demand-for-gloves-so-soon/?ai-debug=0

Old fox is so scared of vaccine everyday come out with new entry for his innocent and naive believers. Lol

Supporting letter is nothing new. Dont be so surprise.

https://koonyewyin.com/2020/08/22/vaccine-will-not-reduce-demand-for-gloves-so-soon/?ai-debug=0

Old fox is so scared of vaccine everyday come out with new entry for his innocent and naive believers. Lol

Accumulation phase could be ending soon. Watch out for next week show!

Moment of silence to those who burnt their underpants at 0.58. RIP

Aiyoooo. Drop so little. Thought can drop till 2.8. Many glove barking here you guys scared of vaccine is it?

Russia says coronavirus vaccine to be tested on 40,000 volunteers amid safety concerns

https://www.cnbc.com/2020/08/20/russia-coronavirus-vaccine-to-be-tested-on-40000-volunteers-research-institute-claims.html

Good Distribution Practice for sterile
Good Manufacturing Practice for sterile

These 2 accreditations are not some ah kok ah peng can acquire over 1-2 months ya. Please dont simply say bio, nova, solution, titi can do and spread false information in forum.

Now ah pek ah kok can sign MOU do fill and finish for vaccine without gmp accreditation. Interesting

The Logistics and Distribution Division turned in a higher PBT of RM37 million for the first six months, up by 96% compared with RM19 million in the same period last year. This was driven by improved contributions from the non-concession business.

The Manufacturing Division posted a PBT of RM13 million on the back of a revenue of RM137 million, in line with order trends from Government hospitals. The outlook remains positive for the Division, with new product launches in the pipeline. In addition, further expansion into overseas markets, as well as increased capacity utilisation via its contract manufacturing business will be pursued by the Group.

The Indonesia Division recorded a deficit of RM2 million. This was mainly attributable to higher finance costs as a result of the delay in payments from government hospitals currently affecting Indonesia’s healthcare industry. The Division was further impacted by Indonesia’s large-scale social restrictions Pembatasan Sosial Berskala Besar in response to the Covid-19 pandemic, which resulted in limited access to doctors, clinics, pharmacies and hospitals.

Pharma steadyyy. Go go go

Based on yesterday’s chart, hammer had formed which is the sign of bullish reversal pattern. Today might be a good day for pharma.

Testing of CanSino's Covid-19 candidate vaccine begins in Russia

https://www.theedgemarkets.com/article/testing-cansinos-covid19-candidate-vaccine-begins-russia

Note that EPF is not a charity fund. How to profit if forever acquire without releasing.

Good sharing Keyman188. Cheers!

warrenG I wonder if you guys actually know about the quarter report yesterday..obviously the investor are not really satisfied with the slight increase in net profit to justify the current stock price, and 0.5 cent dividend compared to 1 cent dividend previous year

Hopefully the ‘investor’ aware that we dont have covid and mco last year. Plus the share appreciation ytd.

Dpharm cc warrant is so tempting guys.

DrLimKH correct... not infected...no need vaccine
13/08/2020 10:18 PM

Uncle you okay or not? Better change your name le. Later people call you anti vaccine doctor...

Sour grapes working extra tonight post green qr release. Even shared old news. Kakakakaka

Chart wise. Serba is waiting to boom once oil is stabilised. Just hold tight and ignore sour grapes.

Aclee007 https://www.orientaldaily.com.my/news/nation/2020/08/13/357583 Ohh no
13/08/2020 7:13 PM

Dont worry. Good news from china is coming soon. Russia’s vaccine is not what we anticipate.

Anticipate this counter to boom. Even Dpharma also reported very greeeeeeen qr :)

Fantastic QR despite lower revenue from private sectors and MCO. Plus dividend!!